Hear what leading medical oncologists have to say about the efficacy of the Guardant360 ® liquid biopsy test
Prof Byoung Chul Cho Professor , Division of Medical Oncology Yonsei Cancer Centre Seoul , South Korea
“ Advanced stage cancer patients who require urgent treatment and may have high risk for tissue biopsy would benefit from Guardant360 . I strongly believe in fast action against growing tumour and Guardant360 has made this possible in my clinic .”
Dr Shaheenah Dawood Consultant Medical Oncologist Mediclinic City Hospital Dubai , U . A . E .
“ In several cases of breast cancer where the disease progresses to the bone , liquid biopsies like Guardant360 become very useful in clinical practice as it ’ s very difficult to biopsy bone . In such cases , this test gives us the comprehensive genomic information required to treat patients appropriately . It also gives us the ability to track mutations that are acquired over time that may help modify therapeutic strategies .”
Dr Tan Yew Oo Specialist in Medical Oncology Icon Cancer Centre Singapore
“ Blood-based liquid biopsies like Guardant360 is a non-invasive test that can complement the traditional techniques should a patient be too unwell to undergo traditional surgical biopsy or should a tumor be inaccessible . This test can also give confirmation to tissue based next generation sequencing analysis at an earlier turnaround time .”
Dr Amit Rauthan Medical Oncologist Department of Medical Oncology Manipal Hospital Bangalore , India
“ The Guardant360 liquid biopsy test was effective in detecting actionable mutations in the solid tumors of my patients with advanced stage cancer and this helped me to make quick , reliable and effective treatment decisions .”
www . guardanthealthamea . com clientservices @ guardantamea . com WhatsApp Hotline : + 65 8940 0360
GlobalHealthAsiaPacific . com AUGUST 2021
25